Encrantz Staffan 4
4 · Sight Sciences, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) 10% Owner Staffan Encrantz Buys Stock
What Happened
Staffan Encrantz, a reported 10% owner of Sight Sciences (SGHT), purchased 14,100 shares of common stock in open‑market transactions on 2026‑06‑10. The reported weighted average price was $4.88 per share, for an aggregate purchase of approximately $68,794. This was a purchase (acquisition), which investors generally view as more informative than routine sales.
Key Details
- Transaction date: 2026-06-10 (Form 4 filed 2026-06-11). Transaction appears timely.
- Transaction type/code: P = Purchase (open market/private purchase).
- Shares acquired: 14,100 shares. Weighted average price: $4.88; total cost ≈ $68,794.
- Price range: per-share prices in the multiple trades ranged from $4.78 to $4.93; Encrantz can provide a breakdown on request (footnote F1).
- Reported holdings referenced in the filing: includes 1,406,022 shares of Common Stock and 28,261 restricted stock units (RSUs) — total cited = 1,434,283 (footnote F2).
- Record/beneficial ownership notes: some shares are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (Encrantz is a trustee) and by Allegro Investment Fund, L.P.; the filer disclaims certain beneficial ownership/pecuniary interests per footnotes F3 and F4.
- No indication of option exercise, gift, tax withholding, or 10b5-1 plan in this filing.
Context
Purchases by insiders can be taken as a positive signal, but for 10% owners (large shareholders or affiliated investors) trades may reflect personal or investment‑fund activity rather than executive views of near‑term company performance. This filing is straightforward: an open‑market acquisition reported the day after the trade.
Insider Transaction Report
Form 4
Encrantz Staffan
Director10% Owner
Transactions
- Purchase
Common Stock
[F1][F2]2026-06-10$4.88/sh+14,100$68,794→ 1,434,283 total
Holdings
- 632,456(indirect: See footnote)
Common Stock
[F3] - 5,086,920(indirect: See footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $4.78 to $4.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes (i)1,406,022 shares of Common Stock and (ii) 28,261 restricted stock units, which restricted stock units are subject to vesting as previously reported.
- [F3]These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any.
- [F4]These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the Chairman and CEO and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Exchange Act. However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, these shares are being reported in this report voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz|2026-06-11